Applications of DNA-based assays in blood group antigen and antibody identification

Transfusion

Volumn 43, Issue 12, 2003, Pages 1748-1757

  Reid, Marion E ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; AUTOMATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; GENE AMPLIFICATION; HEMAGGLUTINATION; HUMAN; INTERMETHOD COMPARISON; PHENOTYPE; POLYMERASE CHAIN REACTION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION; CELL LINE; GENETIC SCREENING; HUMANS;

EID: 0345119169     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2003.00597.x     Document Type: Review

References (87)

1. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272-5.
2. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42-5.
3. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-50.
4. Mullis KB. The unusual origin of the polymerase chain reaction. Sci Am 1990;262:56-65.
5. Lögdberg L, Reid ME, Miller JL. Cloning and genetic characterization of blood group carrier molecules and antigens. Transfus Med Rev 2002;16:1-10.
6. Wagner FF, Poole J, Flegel WA. The Scianna antigens including Rd are expressed by ERMAP. Blood 2003;101: 752-7.
7. Yu LC, Twu YC, Chou ML, et al. The molecular genetics of the human I locus and molecular background explaining the partial association of the adult i phenotype with congenital cataracts. Blood 2003;101:2081-7.
8. k blood group phenotype: identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem 2002;277:29455-9.
9. Chester MA, Olsson ML. The ABO blood group gene: a locus of considerable genetic diversity. Transfus Med Rev 2001;15:177-200.
10. Yamamoto F. Cloning and regulation of the ABO genes. Transfus Med 2001;11:281-94.
11. Olsson ML, Irshaid NM, Hosseini-Maaf B, et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood 2001;98:1585-93.
12. Yamamoto F. Molecular genetics of ABO. Vox Sang 2000;78(Suppl 2):91-103.
13. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375-87.
14. Reid ME, Rios M, Yazdanbakhsh K. Applications of molecular biology techniques to transfusion medicine. Semin Hematol 2000;37:166-76.
15. Cartron JP. Molecular basis of red cell protein antigen deficiencies. Vox Sang 2000;78:7-23.
16. Huang C-H, Liu PZ, Cheng JG. Molecular biology and genetics of the Rh blood group system. Semin Hematol 2000;37:150-65.
17. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000; 37:113-21.
18. Pogo AO, Chaudhuri A. The Duffy protein: a malarial and chemokine receptor. Semin Hematol 2000;37:122-9.
19. Schenkel-Brunner H. Human blood groups: chemical and biochemical basis of antigen specificity. 2nd ed. New York: Springer-Verlag Wien; 2000.
20. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham (NC): Montgomery Scientific Publications; 1998.
21. Reid ME, Lomas-Francis C. The blood group antigen facts book. San Diego: Academic Press; 1996.
22. Daniels G. Human blood groups. Oxford: Blackwell; 1995.
23. Oriol R, Candelier JJ, Mollicone R. Molecular genetics of H. Vox Sang 2000;78:105-8.
24. Reid ME, Storry JR. Low-incidence MNS antigens associated with single amino acid changes and their susceptibility to enzyme treatment. Immunohematology 2001;17:76-81.
25. Wagner T, Vadon M, Staudacher E, et al. A new h allele detected in Europe has a missense mutation in α(1,2)-fucosyltransferase motif II. Transfusion 2001;41:31-8.
26. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans (abstract). BMC Genetics 2001;2.
27. Flegel WA, Wagner FF. Molecular genetics of RH. Vox Sang 2000;78:109-15.
28. Huang CH, Blumenfeld OO. MNSs blood groups and major glycophorins: molecular basis for allelic variation. In: Cartron JP, Rouger P, editors. Molecular basis of human blood group antigens. New York: Plenum; 1995:153-88.
29. Poole J. Red cell antigens on band 3 and glycophorin A. Blood Rev 2000;14:31-43.
30. Zelinski T. Erythrocyte band 3 antigens and the Diego blood group system. Transfus Med Rev 1998;12:36-45.
31. Cuzin M. DNA chips: a new tool for genetic analysis. Transfus Clin Biol 2001;8:291-6.
32. Petrik J. Microarray technology: the future of blood testing? Vox Sang 2001;80:1-11.
33. Miyazato A, Ueno S, Ohmine K, et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 2001;98:422-7.
34. Reid ME, Oyen R, Storry J, et al. Interpretation of RBC typing in multi-transfused patients can be unreliable (abstract). Transfusion 2000;40(Suppl):123S.
35. Reed WF, Lee TH, Trachtenberg E, et al. Detection of microchimerism by PCR is a function of amplification strategy. Transfusion 2001;41:39-44.
36. Wenk RE, Chiafari FA. DNA typing of recipient blood after massive transfusion. Transfusion 1997;37:1108-10.
37. Legler TJ, Eber SW, Lakomek M, et al. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999;39:852-5.
38. Reid ME, Rios M, Powell VI, et al. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000;40:48-53.
39. Rozman P, Dovc T, Gassner C. Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FYblood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions. Transfusion 2000;40:936-42.
40. Reid ME, Yazdanbakhsh K. Molecular insights into blood groups and implications for blood transfusions. Curr Opin Hematol 1998;5:93-102.
41. Cartron JP, Bailly P, Le Van Kim C, et al. Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang 1998;74(Suppl 2):29-64.
42. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-8.
43. Huang CH. Molecular insights into the Rh protein family and associated antigens. Curr Opin Hematol 1997;4:94-103.
44. Reid ME. Molecular basis for blood groups and function of carrier proteins. In: Silberstein LE, editor. Molecular and functional aspects of blood group antigens. Arlington (VA): American Association of Blood Banks; 1995:75-125.
45. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224-8.
46. Müller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41:45-52.
47. Storry JR, Reid ME. Analysis of silenced glycophorin B alleles by PCR-RFLP of exon 5 of the glycophorin B gene (abstract). Transfusion 2000;40(Suppl):13S.
48. Rios M, Hue-Roye K, Lee AH, et al. DNA analysis for the Dombrock polymorphism. Transfusion 2001;41:1143-6.
49. Wu GG, Jin ZH, Deng ZH, Zhao TM. Polymerase chain reaction with sequence-specific primers-based genotyping of the human Dombrock blood group DO1 and DO2 alleles and the DO gene frequencies in Chinese blood donors. Vox Sang 2001;81:49-51.
50. Rios M, Hue-Roye K, Oyen R, et al. Insights into the Holley-negative and Joseph-negative phenotypes. Transfusion 2002;42:52-8.
51. Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97:2879-85.
52. Adinolfi M, Sherlock J, Kemp T, et al. Prenatal detection of fetal RhD DNA sequences in transcervical samples. Lancet 1995;345:318-9.
53. Bennett PR, Overton TG, Lighten AD, Fisk NM. Rhesus D typing. Lancet 1995;345:661-2.
54. Kingdom J, Sherlock J, Rodeck C, Adinolfi M. Detection of trophoblast cells in transcervical samples collected by lavage or cytobrush. Obstet Gynecol 1995;86:283-8.
55. Cheung MC, Goldberg JD, Kan WK. Prenatal diagnosis of sickle cell anemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1997;14:264-8.
56. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
57. Nelson M, Eagle C, Langshaw M, et al. Genotyping fetal DNA by non-invasive means: extraction from maternal plasma. Vox Sang 2001;80:112-6.
58. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
59. Lo YMD. Fetal DNA in maternal plasma: application to noninvasive blood group genotyping of the fetus. Transfus Clin Biol 2001;8:306-10.
60. Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang 2000;78:155-62.
61. Rouillac C, Puillandre P, Colin Y, et al. Fetal RHD typing using DNA from maternal plasma: a prediagnosis study on 182 cases (abstract). Vox Sang 2000;78(suppl 1):26.
62. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
63. Lo YM. Fetal DNA in maternal plasma. Ann N Y Acad Sci 2000;906:141-7.
64. Hahn S, Zhong XY, Burk MR, et al. Multiplex and real-time quantitative PCR on fetal DNA in maternal plasma: a comparison with fetal cells isolated from maternal blood. Ann N Y Acad Sci 2000;906:148-52.
65. Faas BH, Beuling EA, Christiaens GC, et al. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998;352:1196.
66. Bischoff FZ, Nguyen DD, Marquez-Do D, et al. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Invest 1999;6:64-9.
67. Castilho L, Rios M, Violati RG, et al. Prenatal determination of fetal RHD by molecular analysis of maternal plasma (abstract). Transfus Clin Biol 2001;8(Suppl 1):51s.
68. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996;93: 705-8.
69. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186-91.
70. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699-708.
71. Yazdanbakhsh K, Oyen R, Yu Q, et al. High level, stable expression of blood group antigens in a heterologous system. Am J Hematol 2000;63:114-24.
72. Ridgwell K, Dixey J, Parsons SF, et al. Screening human sera for anti-Lu antibodies using soluble recombinant Lu antigens (abstract). Transfus Med 2001;11(Suppl 1):P25.
73. Moulds JM, Brai M, Cohen J, et al. Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998;15:291-4.
74. Daniels GL, Green CA, Powell RM, Ward T. Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion 1998;38:332-6.
75. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999;94:1440-50.
76. Chu THT, Yazdanbakhsh K, Oyen R, et al. Production and characterization of anti-Kell monoclonal antibodies using transfected cells as the immunogen. Br J Haematol 1999;106:817-23.
77. Chu T-HT, Halverson GR, Yazdanbakhsh K, et al. A DNA-based immunization protocol to produce monoclonal antibodies to blood group antigens. Br J Haematol 2001;113:32-6.
78. b for use in the clinical laboratory. Transfusion 2003;43:758-64.
79. Halverson G, Chaudhuri A, Huang T, et al. Immunization of transgenic mice for production of MoAbs directed at polymorphic blood group antigens. Transfusion 2001;41:1393-6.
80. Lee S, Russo DCW, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001;276:27281-9.
81. null individuals. J Biol Chem 1998;273:12973-80.
82. Furukawa K, Iwamura K, Uchikawa M, et al. Molecular basis for the, p phenotype: identification of distinct and multiple mutations in the alpha 1,4-galactosyltransferase gene in Swedish and Japanese individuals. J Biol Chem 2000;275:37752-6.
83. Reid ME, Rios M. Applications of molecular genotyping to immunohaematology. Br J Biomed Sci 1999;56:145-52.
84. Wagner FF, Gassner C, Müller TH, et al. Molecular basis of weak D phenotypes. Blood 1999;93:385-93.
85. Westhoff CM, Silberstein LE, Wylie DE, et al. 16Cys encoded by the RHce gene is associated with altered expression of the e antigen and is frequent in the Ro haplotype. Br J Haematol 2001;113:666-71.
86. Noizat-Pirenne F, Mouro I, Le Pennec PY, et al. Two new alleles of the RHCEgene in Black individuals: the RHceallele ceMO and the RHcE allele cEMI. Br J Haematol 2001;113: 672-9.
87. Noizat-Pirenne F, Lee K, Le Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002;100: 4223-31.